Last reviewed · How we verify
Qishenyiqi dripping pills, 12 bags
Qishenyiqi dripping pills, 12 bags is a Small molecule drug developed by Tasly Pharmaceutical Group Co., Ltd. It is currently in Phase 1 development.
At a glance
| Generic name | Qishenyiqi dripping pills, 12 bags |
|---|---|
| Sponsor | Tasly Pharmaceutical Group Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Qishenyiqi Dripping Pill for Coronary Microvascular Disease (PHASE4)
- Qishenyiqi for Ventricular Remodeling After Myocardial Infarction (PHASE4)
- A Study of Qishenyiqi Dripping Pills in Healthy Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Qishenyiqi dripping pills, 12 bags CI brief — competitive landscape report
- Qishenyiqi dripping pills, 12 bags updates RSS · CI watch RSS
- Tasly Pharmaceutical Group Co., Ltd portfolio CI
Frequently asked questions about Qishenyiqi dripping pills, 12 bags
What is Qishenyiqi dripping pills, 12 bags?
Qishenyiqi dripping pills, 12 bags is a Small molecule drug developed by Tasly Pharmaceutical Group Co., Ltd.
Who makes Qishenyiqi dripping pills, 12 bags?
Qishenyiqi dripping pills, 12 bags is developed by Tasly Pharmaceutical Group Co., Ltd (see full Tasly Pharmaceutical Group Co., Ltd pipeline at /company/tasly-pharmaceutical-group-co-ltd).
What development phase is Qishenyiqi dripping pills, 12 bags in?
Qishenyiqi dripping pills, 12 bags is in Phase 1.